An altered MCT1 level has been reported in McArdle disease [Glycogen Storage Disease Type V; MD), a metabolic myopathy characterised by the absence of glycogenolysis due to a deficiency in muscle glycogen phosphorylase [80]. Here, SLC16A1 is linked to glycogen storage disease V.